Photo Rounds

Pain in right shoulder

Author and Disclosure Information

 

References

Treat with disease-modifying antirheumatic drugs

Immediate treatment of RA with disease-modifying antirheumatic drugs (DMARDs) is important to achieve control of the disease and prevent disability.

Our patient. We ordered a purified protein derivative skin test in preparation for the patient to start therapy with a DMARD. Our patient followed up with Rheumatology and was started on indomethacin, with an initial dose of 25 mg bid. (DMARDs are first-line therapy; indomethacin is a second-line choice. In this case, the patient declined DMARDs after hearing they lowered the body’s ability to fight infection.) An RF level measured 6.74 IU/ml, which is within normal limits. The patient was subsequently lost to follow-up.

CORRESPONDENCE
Barbara Kiersz, DO, 6835 Austin Center Blvd., Austin, TX 78731; bmkiersz@gmail.com.

Pages

Recommended Reading

Functional disability prevails despite rheumatoid arthritis treatment
MDedge Family Medicine
Ankylosing spondylitis diagnosis linked to self-harm attempts
MDedge Family Medicine
TNF inhibitor linked to one-third drop in total mortality
MDedge Family Medicine
Low vitamin D linked with DVT in lupus patients
MDedge Family Medicine
Inflammatory myopathy following tattoo reported in an immunocompromised patient
MDedge Family Medicine
Biologics improve axial spondyloarthritis patients’ work performance
MDedge Family Medicine
Canakinumab cut gout attacks in CANTOS
MDedge Family Medicine
Severe OA sparks depression, surgery “ameliorates” depression in RA
MDedge Family Medicine
Heart failure confers poor prognosis in rheumatoid arthritis
MDedge Family Medicine
Pain remains after rheumatoid arthritis diagnosis
MDedge Family Medicine